×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Barrowcliffe Susan E.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeNov 19, 2018Sale$16.5380,0001,322,48049,375Nov 21, 2018, 04:05 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJan 02, 2018Sale$20.08150,0003,011,84075,000Jan 04, 2018, 12:00 AM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeSep 25, 2017Sale$14.0140,000560,44020,000Sep 27, 2017, 04:05 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeSep 05, 2017Sale$12.516,44680,6463,223Sep 07, 2017, 04:05 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeSep 06, 2017Sale$12.5130,334379,54415,167Sep 07, 2017, 04:05 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJul 27, 2017Sale$12.511,00012,511500Jul 31, 2017, 05:50 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJul 21, 2017Option Exercise$12.511,92024,021960Jul 25, 2017, 06:35 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJul 24, 2017Sale$12.511,00012,511500Jul 25, 2017, 06:35 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJul 25, 2017Sale$12.519,300116,3524,650Jul 25, 2017, 06:35 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeJul 03, 2017Option Exercise$11.6430,000349,24115,000Jul 06, 2017, 04:05 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeNov 11, 2016Option Exercise$14.0140,000560,44020,000Nov 15, 2016, 04:06 PM
AIMTAimmune Therapeutics, Inc.Barrowcliffe Susan E.General Manager, EuropeNov 08, 2016Option Exercise$11.5130,000345,33015,000Nov 10, 2016, 04:05 PM